Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8785781 | Cancer Treatment Reviews | 2018 | 27 Pages |
Abstract
LRR patterns are well-known and for selected patients, adjuvant treatments could target this event. Intrinsic tumor subtype may guide future criteria to define a personalized treatment strategy. Prospective trials evaluating safety and efficacy of adjuvant RT are ongoing in several countries.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Paul Sargos, Brian C. Baumann, Libni Eapen, John Christodouleas, Amhit Bahl, Vedang Murthy, Jason Efstathiou, Valérie Fonteyne, Leslie Ballas, Mohamed Zaghloul, Guilhem Roubaud, Mathieu Orré, Stéphane Larré,